GRI BIO, INC. — Income Charts
13 quarters of history · ending 2023-03-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+1700.0% +$17K
$16K
R&D↓-90.9% -$1M
$116K
SG&A↑+121.3% +$455K
$830K
D&A
$1K
Operating Income↑+62.5% +$2M
$-988K
EBITDA↑+62.5% +$2M
$-987K
Interest Expense
$-1M
Tax Provision
$0
Net Income↓-611.9% -$2M
$-2M
Operating Margin↓-269575.0pts
-6175.0%
Net Margin↓-43637.5pts
-13437.5%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-2.9pts
7.7%
Revenue YoY Variation
1700.0%
Income YoY Variation↑+63.7pts
62.5%
Revenue QoQ Variation↑+400.0pts
300.0%
Income QoQ Variation↓-44.2pts
1.6%